How APOE4 and menopause-related hormone changes link to Alzheimer's risk in women
Impact of APOE4 on sex-specific mechanism for Alzheimer's disease
This project looks at whether the APOE4 gene and changes in hormones around menopause help drive Alzheimer's disease in women.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11247561 on NIH RePORTER |
What this research studies
From a patient's point of view, researchers are following clues about why women develop Alzheimer's more often and how the APOE4 gene might interact with menopause-related hormones. The team will study the C/EBPb/d-secretase molecular pathway that appears to be activated by both APOE4 and elevated follicle-stimulating hormone (FSH). Work will combine laboratory cell and animal experiments and molecular analysis that connect those findings back to human Alzheimer's biology. The goal is to pinpoint mechanisms that could point toward treatments for women at higher risk.
Who could benefit from this research
Good fit: This research is most relevant to postmenopausal women, particularly those who carry the APOE4 gene or who are experiencing early memory problems.
Not a fit: People who do not carry APOE4, men, or those with non-Alzheimer's dementias are less likely to see direct benefit from findings focused on APOE4 and menopause-related mechanisms.
Why it matters
Potential benefit: If successful, this work could point to new ways to prevent or treat Alzheimer's in postmenopausal women, especially those with the APOE4 risk gene.
How similar studies have performed: Previous animal and molecular studies have linked APOE4 and menopause hormones to Alzheimer's biology and showed that blocking FSH improved cognition in AD mice, but human benefits remain unproven.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Kang, Seong Su — Emory University
- Study coordinator: Kang, Seong Su
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.